Matthew E Voss

age ~67

from Durham, NC

Get Report

Also known as:

Matthew Ernst Voss

Connected to:

Matthew Voss Phones & Addresses

Durham, NC
26 Corporate Cir, Albany, NY 12203
181 Hoags Corners Rd, Nassau, NY 12123 • 518 766-9101
101 Hoags Corners Rd, Nassau, NY 12123
Clifton, NJ
106 Westview Dr, Lincoln University, PA 19352 • 610 255-0546
8 Westview Dr, Lincoln University, PA 19352
Columbia, SC
Rensselaer, NY
Lincoln Univ, PA

Work

Position:

Apps in the app store / contributor

Education

School / High School:

Pensacola Christian College
2001
Specialities:

Computer Science

Name / Title

Company / Classification

Phones & Addresses

Matthew Voss
Mbr

Kivo Consulting, Llp
Computer Related Services Business Services at Non-Commercial Site · Computer Related Services, Nec, Nsk

208 Chesapeake Rdg Ln, Northeast, MD 21901

Medicine Doctors

Matthew R. Voss

view source

Specialties:

Cardiovascular Disease

Work:

Maryland Cardiovascular Specialist
3407 Wilkens Ave STE 300, Baltimore, MD 21229
410 644-5111 (phone), 410 644-2715 (fax)

Education:

Medical School
Southern Illinois University School of Medicine
Graduated: 1998

Procedures:

Angioplasty
Cardiac Stress Test
Pacemaker and Defibrillator Procedures
Cardiac Catheterization
Cardioversion
Continuous EKG
Echocardiogram
Electrocardiogram (EKG or ECG)

Conditions:

Mitral Valvular Disease
Abdominal Hernia
Acute Myocardial Infarction (AMI)
Anemia
Anxiety Phobic Disorders

Languages:

English
Spanish

Description:

Dr. Voss graduated from the Southern Illinois University School of Medicine in 1998. He works in Baltimore, MD and specializes in Cardiovascular Disease. Dr. Voss is affiliated with Medstar Union Memorial Hospital, Saint Agnes Hospital, University Of Maryland Saint Joseph Medical Center and University Of Maryland Upper Chesapeake Medical Center.

Matthew R. Voss

view source

Specialties:

Family Medicine

Work:

Manchester Community Health Center
145 Hollis St FL 2, Manchester, NH 03101
603 626-9500 (phone), 603 626-9523 (fax)

Languages:

Arabic
English
Spanish

Description:

Mr. Voss works in Manchester, NH and specializes in Family Medicine. Mr. Voss is affiliated with Elliot Hospital.

License Records

Matthew Voss

License #:

27392 - Expired

Category:

Nursing Support

Issued Date:

Aug 11, 1994

Effective Date:

May 28, 1998

Type:

Nurse Aide

Lawyers & Attorneys

Matthew Voss - Lawyer

view source

ISLN:

916797636

Admitted:

2001

University:

University of Nevada, Las Vegas, B.A., 1998

Law School:

University of California at Berkeley, J.D., 2001

Matthew Voss - Lawyer

view source

Specialties:

Health Care
Copyright Infringement
Copyright Infringement
Civil Litigation
Insurance Defense
Construction Defects

ISLN:

913986699

Admitted:

1998

University:

Illinois State University, B.S., 1993

Law School:

Southwestern University School of Law, J.D., 1997

Resumes

Senior Manager Engineering

view source

Location:

Albany, NY

Industry:

Medical Devices

Work:

Philips Nov 2012 - May 2018
Project Manager, New Product Development
Philips Nov 2012 - May 2018
Senior Manager Engineering
Philips Jul 2009 - Nov 2012
Mechanical Engineer
General Electric Transportation May 2008 - Aug 2008
Mechanical Engineer, Intern
Washington University In St. Louis Jun 2007 - Aug 2007
Mechanical Engineer, Intern

Education:

Case Western Reserve University 2019 - 2022
Master of Science, Masters, Mechanical Engineering Case Western Reserve University 2005 - 2009
Bachelors, Bachelor of Science, Mechanical Engineering

Skills:

Ansys
Sinda
Mathcad
Inventor
Solidworks
Autocad
Vba
Java
Microsoft Office
Mechanical Engineering
Testing
Product Development

Senior Director

view source

Location:

Durham, NC

Industry:

Pharmaceuticals

Work:

Parion Sciences
Senior Director
Amri (Albany Molecular Research Inc.) Jul 2012 - May 2017
Section Head
Amri (Albany Molecular Research Inc.) Feb 1, 2011 - Jul 1, 2012
Senior Project Leader Singapore
Amri (Albany Molecular Research Inc.) Aug 1, 2003 - Feb 1, 2011
Senior Research Scientist Iii
Bristol-Myers Squibb Sep 1, 2001 - Jan 1, 2003
Senior Research Scientist

Education:

University of Rochester 1980 - 1986
Doctorates, Doctor of Philosophy, Organic Chemistry University of South Carolina 1976 - 1980
Bachelors, Bachelor of Science, Chemistry

Skills:

Organic Synthesis
Medicinal Chemistry
Organic Chemistry
Drug Discovery
Drug Development
Drug Design
Chemistry
Heterocyclic Chemistry
Lead Change
Oncology
Synthetic Organic Chemistry
Parallel Synthesis
Nmr
Hplc
Pharmaceutical Research
Analytical Chemistry
Biochemistry
Purification
Chromatography
Pharmaceutical Industry
Technology Transfer
Pharmacology
Life Sciences
Natural Products
Scifinder
Lc Ms
Lifesciences
Dmpk
Mass Spectrometry
Drug Metabolism
Drug Safety
Protein Kinases
Kinases
Drug Testing

Pastor At Life Church

view source

Location:

United States

Industry:

Religious Institutions

Matthew Voss

view source

Matthew Voss

view source

Work:

Apps in the App Store / Contributor
Dec 2013 to Jun 2014

Education:

Pensacola Christian College
2001 to 2003
Computer Science

Us Patents

Substituted Aryl Hydroxamic Acids As Metalloproteinase Inhibitors
view source
US Patent:

6365587, Apr 2, 2002
Filed:

May 13, 1999
Appl. No.:

09/312066
Inventors:

Matthew E. Voss - Lincoln University PA 19352
Carl P. Decicco - Newark DE 19711
Ruth R. Wexler - Wilmington DE 19810
International Classification:

A61K 31541
US Classification:

5142275, 5142222, 5142268, 5142278, 5142288, 5142355, 5142372, 51425201, 51425203, 51425301, 514258, 544 3, 544 54, 544 584, 544 63, 544 89, 544 96, 544 97, 544128, 544131, 544225, 544238, 544239, 544333, 544335, 544360, 544383, 544399
Abstract:

The present application describes novel substituted aryl hydroxamic acids of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring A is a 5-8 membered ring containing from 0-1 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors.

Cyclic Sulfonamide Derivatives As Metalloproteinase Inhibitors
view source
US Patent:

6455522, Sep 24, 2002
Filed:

Feb 10, 1999
Appl. No.:

09/247675
Inventors:

Jingwu Duan - Newark DE
Lihua Chen - Wilmington DE
Robert J. Cherney - Newark DE
Carl P. Decicco - Newark DE
Matthew E. Voss - Lincoln University PA
Assignee:

Bristol-Myers Squibb Pharma Company - Princeton NJ
International Classification:

A61K 3155
US Classification:

514221, 544 47, 548122, 540490, 540491
Abstract:

The present application describes novel lactams and derivatives thereof of formula I: or pharmaceutically acceptable salt forms thereof, wherein rings ring B is a 4-8 membered cyclic sulfonamide containing from 0-3 additional heteroatoms selected from N, O, and S, which are useful as metalloprotease inhibitors.

-Amino Acid Derivatives As Inhibitors Of Matrix Metalloproteases And Tnf-
view source
US Patent:

6495565, Dec 17, 2002
Filed:

Mar 16, 2001
Appl. No.:

09/811116
Inventors:

Jingwu Duan - Newark DE
Bryan W. King - Wilmington DE
Carl Decicco - Kennett Square PA
Matthew E. Voss - Lincoln University PA
Assignee:

Bristol-Myers Squibb Pharma Company - Princeton NJ
International Classification:

A61K 314709
US Classification:

514314, 546175, 546152, 514311
Abstract:

The present application describes novel -amino acid derivatives of formula I: or pharmaceutically acceptable salt or prodrug forms thereof, wherein A, X, Z, U , X , Y , Z , R , R , R , R , and R are defined in the present specification, which are useful as metalloprotease and/or as TNF- inhibitors.

Spiro-Cyclic -Amino Acid Derivatives As Inhibitors Of Matrix Metalloproteases And Tnf- Converting Enzyme (Tace)
view source
US Patent:

6720329, Apr 13, 2004
Filed:

Mar 12, 2002
Appl. No.:

10/096804
Inventors:

Gregory R. Ott - Media PA
Xiao Tao Chen - Newark DE
Jingwu Duan - Newark DE
Matthew E. Voss - Lincoln University PA
Assignee:

Bristol-Myers Squibb Pharma - Princeton NJ
International Classification:

A61K 31443
US Classification:

514278, 514342, 514339, 514336, 546 15, 546152, 5462681, 5462764, 5462797, 5462817
Abstract:

The present application describes novel spiro-cyclic -amino acid derivatives of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring B is a 3-13 membered carbocycle or heterocycle, ring C forms a 3-11 membered spiro-carbocycle or spiro-heterocycleon ring B, and the other variables are defined in the present specification, which are useful as as matrix metalloproteinases (MMP), TNF- converting enzyme (TACE), and/or aggrecanase inhibitors.

Bicyclic Lactam Derivatives As Inhibitors Of Matrix Metalloproteinases And/Or Tnf-Α Converting Enzyme (Tace)
view source
US Patent:

6884806, Apr 26, 2005
Filed:

Oct 16, 2002
Appl. No.:

10/271441
Inventors:

Carl P. Decicco - Kennett Square PA, US
Ying Song - Hockessin DE, US
Jingwu Duan - Newark DE, US
Matthew E. Voss - Lincoln University PA, US
Assignee:

Bristol-Myers Squibb Company - Princeton NJ
International Classification:

C07D471/04
C07D455/02
A61K031/47
A61K031/4745
A61P019/02
US Classification:

514299, 514306, 546138, 546183
Abstract:

The present application describes novel bicyclic lactam derivatives of formula I: or pharmaceutically acceptable salt forms thereof, wherein A, B, C, D, R, and Rare defined in the present specification, which are useful as metalloprotease, TNF-α, and/or aggrecanase inhibitors.

Spiro-Cyclic Β-Amino Acid Derivatives As Inhibitors Of Matrix Metalloproteases And Tnf-Α Converting Enzyme (Tace)
view source
US Patent:

6962938, Nov 8, 2005
Filed:

Dec 18, 2003
Appl. No.:

10/741326
Inventors:

Gregory R. Ott - Media PA, US
Xiao Tao Chen - Furlong PA, US
Jingwu Duan - Yardley PA, US
Matthew E. Voss - Lincoln University PA, US
Assignee:

Bristol-Myers Squibb Pharma Company - Princeton NJ
International Classification:

A61K031/403
A61K031/38
C07D327/04
C07D207/04
C07D207/18
US Classification:

514409, 514438, 514462, 549 30, 549200, 549300, 549322, 549337, 549341, 548407
Abstract:

The present application describes novel spiro-cyclic β-amino acid derivatives of formula I: or pharmaceutically acceptable salt forms thereof, wherein ring B is a 3-13 membered carbocycle or heterocycle, ring C forms a 3-11 membered spiro-carbocycle or spiro-heterocycleon ring B, and the other variables are defined in the present specification, which are useful as as matrix metalloproteinases (MMP), TNF-α converting enzyme (TACE), and/or aggrecanase inhibitors.

Vinorelbine Derivatives
view source
US Patent:

7235564, Jun 26, 2007
Filed:

Dec 3, 2004
Appl. No.:

11/003583
Inventors:

Ian L. Scott - Woodinville WA, US
Jeffrey M. Ralph - Niskayuna NY, US
Matthew E. Voss - Nassau NY, US
Assignee:

AMR Technology, Inc. - Manchester Center VT
International Classification:

A61P 35/00
A61K 31/4745
C07D 487/22
US Classification:

514283, 540478
Abstract:

The present invention relates to novel vinorelbine derivatives. Pharmaceutical compositions containing these compounds as well as processes of preparation and processes of use for treatment of various conditions are also disclosed.

Vinca Derivatives
view source
US Patent:

7238704, Jul 3, 2007
Filed:

Dec 3, 2004
Appl. No.:

11/003560
Inventors:

Ian L. Scott - Woodinville WA, US
Jeffrey M. Ralph - Niskayuna NY, US
Matthew E. Voss - Nassau NY, US
Assignee:

AMR Technology, Inc. - Manchester Center VT
International Classification:

A61P 35/00
A61K 31/4745
C07D 487/22
US Classification:

514283, 540478
Abstract:

The present invention relates to derivatives of vinca alkaloids. Pharmaceutical compositions containing these compounds as well as processes of preparation and treatment of various conditions are also disclosed.